Table of Contents
Headache Research and Treatment
Volume 2011, Article ID 319563, 5 pages
Clinical Study

Migraine-Related Vertigo: Eight Years of Experience with Pharmacologic Prophyilaxis

1Azienda Ospedaliera di Pordenone, Unità Operativa di Otorinolaringoiatria, Via Montereale, 33170 Pordenone, Italy
2Head and Neck Surgery Department, General Hospital, Pordenone, Italy
3Department of Medical and Surgical Specialties, Section of Otolaryngology, Padua University, Padua, Italy

Received 30 July 2010; Revised 22 February 2011; Accepted 30 March 2011

Academic Editor: Christian Wöber

Copyright © 2011 Arturo Maione et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In 2001, our dizziness unit elaborated a diagnostic-therapeutic protocol for patients affected by migraine-related vertigo (MRV). This protocol contemplated the selection from March 2001 to December 2009 of 98 patients affected by MRV out of 1357 consecutive patients who came to our dizziness unit and the administration of pharmacologic prophylaxis. The results obtained constitute the object of this prospective, observational study. The efficacy of a 6-month treatment was registered by the patients by means of a self-assessment questionnaire where the results were divided into 5 categories, and, in case of patients with recurrent vertiginous attack, we recorded the percentage of the reduction in the frequency of the attacks. Of the sixty-four patients who completed the treatment, 43 (67.2%) reported complete resolution or substantial control, and, of the 57 patients suffering from recurrent vertigo attacks, 44 (77.2%) reported a reduction in the frequency of the attacks of at least 50%.